Creating a Path for Progressive CDI Programs: Learning Series 2022 - CMS Fiscal Year 2023 ICD-10-CM/PCS Updates

September 28, 2022

After completing this program, attendees will understand the most significant changes to the Fiscal Year 2023 ICD-10-CM and ICD-10-PCS Official Guidelines for Coding and Reporting and updated ICD-10-CM diagnosis and ICD-10-PCS procedure codes.  The attendees will also understand the impact of these changes to MS-DRG assignment and the capture of variables, particularly social determinants of health, affecting national scorecard rankings. 

Target Audience


CDI Specialists


Learning Objectives

1.    Apply the Fiscal Year 2023 additions, deletions and modifications to ICD-10-CM Complications and Comorbidities (CC) and Major Complications and Comorbidities (MCC) and ICD-10-PCS procedure codes. 
2.    Describe noteworthy changes to the Fiscal Year 2023 ICD-10-CM and ICD-10-PCS Official Guidelines for Coding and Reporting. 
3.    Interpret Fiscal Year 2023 ICD-10-CM and ICD-10-PCS guideline and code changes as it pertains to Clinical Documentation Improvement and inpatient coding and MS-DRG assignment. 
4.    Discuss significant Fiscal Year 2023 changes to MS-DRG assignment, relative weights, and Geometric Mean Length of Stay (GMLOS). 
5.    Describe the impact of application of Social Determinants of Health codes relative to capture of variables supporting national scorecard rankings.

Course summary
Available credit: 
  • 1.50 ANCC
  • 1.50 CBRN
  • 1.50 General CE – Attendance
Course opens: 
Course expires: 
Event starts: 
09/28/2022 - 12:00pm CDT
Event ends: 
09/28/2022 - 1:30pm CDT
Live activity
United States

Identification, Mitigation, and Disclosure of Relevant Financial Relationships

As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.


Ineligible companies those companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.


It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.


FDA Off-Label Use

Faculty presenters are also expected to disclose any discussion of (1) off-label or investigational uses of FDA approved commercial products or devices or (2) products or devices not yet approved in the United States.




The following planners, faculty, and others in control of educational content have no relevant financial relationships with ineligible companies.


Planning committee members


Rachel Mack, RN, MSN, BA, CCDS, CDIP, CCS, CRC

Consulting Director, CDI

Vizient, Inc.


Angela Hunt, RN, MBA, CCDS

Associate Principal, Advisory Solutions

Vizient Inc.


Linda Wiseman, RN, BSN, CCDS

Consulting Director, CDI

Vizient Inc.


Jim Tamburini, BS, RHIT, CCS, CCS-P, CDIP

Consulting Director, CDI

Vizient Inc.


Sheila Bowlds, RHIA, MBA, AHIMA Certified ICD-10 Trainer

Consulting Director, CDI

Vizient Inc.


Terry Golde, MBA, RN, CCDS

Consulting Director, CDI

Vizient Inc.


Erica Braun, MS, BSN, RN, CCDS

Consulting Director, CDI

Vizient Inc.


Marly Christenson, PhD, MS, RN, NP, CPHQ

Senior Director /Nurse Planner

Vizient Inc.




Sheila Bowlds, MBA, RHIA, AHIMA ICD-10 Trainer

Senior Consulting Director



Amber Sterling, RN, BSN, CCDS

Consulting Director



James Tamburini, BS, RHIT, CCS, CDIP

Senior Consulting Director



Joint Accreditation Statement:

In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


Designation Statement(s):

This activity is designated for 1.50 contact hours.

Vizient, Inc. is approved by the California Board of Registered Nursing, Provider Number CEP12580, for 1.50 contact hours.

Vizient, Inc. will award all other healthcare professionals who successfully complete the activity a Certificate of Participation indicating the maximum credits available. Various state license boards and credentialing bodies accept certificates of participation from accredited CE activities to meet CE requirements for license renewals and re-certification. It is the responsibility of the participant to contact their state licensing board and/or certifying body for verification on credit eligibility reciprocity.


Available Credit

  • 1.50 ANCC
  • 1.50 CBRN
  • 1.50 General CE – Attendance
Please login or register to take this course.